Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Orgenesis Inc. (ORGS)
|
Add to portfolio |
|
|
|
| Price: |
$2.90
| | Metrics |
| OS: |
28.5
|
M
| |
57
|
% ROE
|
| Market cap: |
$82.6
|
M
| |
-20
|
% ROIC
|
|
Net cash:
|
$11.5
|
M
| |
$0.40
|
per share
|
|
EV:
|
$71.1
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
($2.8)
|
M
| |
|
|
|
EBIT
|
($5.0)
|
M
| |
|
|
| EPS |
$0.52
| |
5.6
|
x P/E
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Nov-30-18 | Nov-30-17 | Nov-30-16 | Nov-30-15 |
| Revenues | 36.0 | 35.5 | 7.7 | 3.9 | 2.6 | 10.1 | 6.4 | 3.0 |
| Revenue growth | 1.5% | 364.0% | 96.3% | | -74.6% | 57.7% | 115.1% | 173.8% |
| Cost of goods sold | 27.1 | 36.6 | -191.6 | -44.0 | 5.8 | 6.8 | 7.7 | 3.9 |
| Gross profit | 9.0 | -1.1 | 199.2 | 47.8 | -3.2 | 3.3 | -1.3 | -0.9 |
| Gross margin | 24.9% | -3.2% | 2603.4% | 1227.2% | -125.6% | 32.5% | -19.7% | -30.5% |
| Selling, general and administrative | 15.6 | 14.7 | 19.0 | 11.5 | 12.9 | | | |
| Research and development | | | 84.0 | 14.0 | | 2.5 | 2.2 | 1.1 |
| General and administrative | | | | | | 9.2 | 6.2 | 4.0 |
| EBITA | -5.1 | -15.6 | 96.3 | 22.4 | -8.4 | -8.4 | -9.8 | -6.0 |
| EBITA margin | -14.2% | -43.9% | 1258.0% | 574.6% | -328.7% | -83.1% | -152.9% | -202.0% |
| Amortization of intangibles | 0.9 | 0.9 | 0.5 | 0.4 | 1.9 | 1.6 | 1.6 | 1.2 |
| EBIT | -6.0 | -16.5 | 95.8 | 22.0 | -10.3 | -10.0 | -11.4 | -7.2 |
| EBIT margin | -16.7% | -46.6% | 1251.7% | 563.6% | -403.4% | -99.3% | -178.2% | -242.5% |
| Pre-tax income | 12.0 | 18.0 | 96.7 | 22.8 | -17.8 | 13.7 | 12.7 | 5.4 |
| Income taxes | -0.2 | -0.1 | 1.6 | 0.2 | 1.3 | -1.3 | 1.5 | 0.9 |
| Tax rate | | | 1.7% | 1.0% | | | 12.2% | 16.8% |
| Earnings from continuing ops | 14.9 | 18.1 | 93.3 | 22.6 | -18.3 | 12.4 | 11.1 | 4.5 |
| Earnings from discontinued ops | | | 1.2 | 3.5 | | | | |
| Net income | 14.9 | 18.1 | 94.5 | 26.0 | -18.3 | 12.4 | 11.1 | 4.5 |
| Net margin | 41.3% | 50.9% | 1235.6% | 667.9% | -713.4% | 122.6% | 173.7% | 150.0% |
| |
| Diluted EPS | $0.59 | $0.74 | $4.38 | $1.42 | ($1.37) | $1.27 | $1.30 | $0.08 |
| Shares outstanding (diluted) | 25.1 | 24.3 | 21.3 | 15.9 | 13.4 | 9.7 | 8.5 | 56.9 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|